Ubs Group Ag Ensysce Biosciences, Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.05 - $153.6 $1,752 - $5.38 Million	35,055 Added 205.16%	52,142 $11,000
Q2 2022 Aug 10, 2022	BUY	$100.8 - $345.6 $918,590 - $3.15 Million	9,113 Added 114.28%	17,087 $15,000
Q1 2022 May 16, 2022	SELL	$230.4 - $1140.0 $434,764 - $2.15 Million	-1,887 Reduced 19.14%	7,974 $9,000
Q4 2021 Feb 14, 2022	BUY	$300.0 - $1228.8 $2.96 Million - $12.1 Million	9,861 New	9,861 $46,000

100

Ticker ENSC
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,918,900
Market Cap $1.21M
Description
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.